Drug formulation technologists are specialized experts who focus on the development and refinement of pharmaceutical products to ensure that drugs deliver their intended therapeutic effects safely and efficiently. Their responsibilities include designing formulations that balance drug stability, solubility, and bioavailability while maintaining patient compliance. They work with a range of dosage forms such as tablets, capsules, injectables, and topical applications, selecting appropriate excipients and optimizing processing parameters. By using advanced techniques and scientific knowledge, these technologists ensure that the final drug product meets rigorous quality standards and regulatory requirements.
Besides formulation development, drug formulation technologists are involved in scaling up processes from the laboratory to commercial manufacturing, ensuring reproducibility and cost-effectiveness. They conduct thorough evaluations, including stability testing, dissolution profiling, and compatibility assessments, to guarantee product performance throughout its shelf life. Collaboration with cross-functional teams—such as regulatory affairs, quality control, and production—is essential to address challenges and accelerate time-to-market. As the pharmaceutical landscape evolves with emerging technologies like controlled-release systems and nanocarriers, drug formulation technologists continue to play a pivotal role in advancing drug delivery science and improving patient outcomes worldwide. Their expertise is crucial in driving innovation and ensuring that new medicines reach patients safely and efficiently. Ultimately, their work helps transform scientific discoveries into practical treatments that improve global health.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia